Gelonghui March 3rd 丨Huahai Pharmaceutical (600521.SH) announced that as of March 3, 2023, the closing price of the company's shares had been below 80% of the current conversion price for at least 10 trading days out of 30 consecutive trading days. “Huahai Convertible Bonds” are expected to trigger downward revision conditions in the conversion price. If the condition is triggered, the company will hold a board of directors on the day the condition is triggered to review and decide whether to revise the conversion price and promptly fulfill the obligation to disclose information.
华海药业(600521.SH):“华海转债”预计触发转股价向下修正的条件
Huahai Pharmaceutical (600521.SH): “Huahai debt conversion” is expected to trigger a downward correction in the conversion price
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.